Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration

(2014) S. W. S. Yapa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia

(2013) Yu-long Zheng et al.   AMERICAN JOURNAL OF INFECTION CONTROL

The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies

(2013) Kyung-Hwa Park et al.   PLoS One

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)

(2012) X. Schleicher et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia

(2012) Shih-Tse Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Emergence of Carbapenem-Resistant Non-baumannii Species of Acinetobacter Harboring ablaOXA-51-Like Gene That Is Intrinsic to A. baumannii

(2011) Yi-Tzu Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter

(2011) Paula Espinal et al.   Future Microbiology

Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea

(2011) Young Kyoung Park et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway

(2011) Nabil Karah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes

(2011) Y.-C. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States

(2011) Hilmar Wisplinghoff et al.   JOURNAL OF INFECTION

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)

(2011) Alexandr Nemec et al.   RESEARCH IN MICROBIOLOGY

Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia

(2010) Y.-C. Chuang et al.   CLINICAL INFECTIOUS DISEASES

Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics

(2009) A. Y. Peleg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Acinetobacter Infection

(2008) L. Silvia Munoz-Price et al.   NEW ENGLAND JOURNAL OF MEDICINE